HVCN1: A Potential Drug Target Or Biomarker (G84329)

Target Name: HVCN1

NCBI ID: G84329

HVCN1

HVCN1: A Potential Drug Target Or Biomarker

Hydrogen voltage gated channel 1 (HVCN1), also known as Transcript Variant 1, is a protein that plays a crucial role in various physiological processes in the human body. It is a voltage-dependent chloride channel that is expressed in the heart, kidneys, and other organs. It is known to be involved in neurotransmitter release, pain perception, and other physiological processes.

Recent studies have suggested that HVCN1 may have potential as a drug target or biomarker. HVCN1 has been shown to play a role in neurotransmitter release, which is a critical mechanism in the brain that is responsible for many different functions, including mood, pain perception, and appetite. Additionally, HVCN1 has been linked to the development of certain diseases, such as epilepsy and migraine.

One of the key features of HVCN1 is its voltage-dependent properties. When HVCN1 is activated, it allows chloride ions to flow into the cell, which can cause a change in the electrical potential of the cell. This change in potential is important for the function of the channel, as it helps to regulate the flow of ions into and out of the cell.

In addition to its role in neurotransmitter release, HVCN1 is also involved in the regulation of pain perception. Studies have shown that HVCN1 is involved in the development of pain sensations and that it may play a role in the treatment of chronic pain. This is because when HVCN1 is activated, it can cause a change in the electrical potential of the cell, which can contribute to the sensation of pain.

Another potential application of HVCN1 as a drug target is its role in the development of certain diseases. For example, HVCN1 has been linked to the development of epilepsy, a disease that causes the brain to have an abnormal electrical activity. Additionally, HVCN1 has been linked to the development of migraine, a type of headache that is characterized by intense pain and sensitivity to light.

In conclusion, HVCN1 is a protein that plays a crucial role in various physiological processes in the human body. Its voltage-dependent properties and its involvement in neurotransmitter release, pain perception, and the development of certain diseases make it an attractive target for research and development as a drug or biomarker. Further studies are needed to fully understand the role of HVCN1 in these processes and to explore its potential as a drug or biomarker.

Protein Name: Hydrogen Voltage Gated Channel 1

Functions: Mediates the voltage-dependent proton permeability of excitable membranes. Forms a proton-selective channel through which protons may pass in accordance with their electrochemical gradient. Proton efflux, accompanied by membrane depolarization, facilitates acute production of reactive oxygen species in phagocytosis

The "HVCN1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HVCN1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets